Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerosis, Systemic”

828 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 828 results

Testing effectiveness (Phase 2)Looking for participantsNCT03582800
What this trial is testing

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

Who this might be right for
Systemic SclerosisDermatomyositisiPPSD2
University Hospital, Limoges 40
Not applicableUnknownNCT05821335
What this trial is testing

Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis

Who this might be right for
RheumatologyScleroderma, SystemicVideo Games+3 more
Istanbul University 32
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Early research (Phase 1)Looking for participantsNCT06980597
What this trial is testing

OL-108 in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+1 more
Beijing GoBroad Hospital 44
Very early researchStudy completedNCT03060551
What this trial is testing

Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients

Who this might be right for
Systemic Sclerosis
Suk-Ho Moon 20
Not applicableStudy completedNCT06373263
What this trial is testing

Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 511
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778446
What this trial is testing

Test CRT-402 in Refractory Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Scleroderma+1 more
Myeloid Therapeutics 34
Early research (Phase 1)Ended earlyNCT04478994
What this trial is testing

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Amgen 3
Testing effectiveness (Phase 2)UnknownNCT02551042
What this trial is testing

CSL Behring Sclero XIII

Who this might be right for
Systemic Sclerosis
University College, London 26
Large-scale testing (Phase 3)Study completedNCT04274257
What this trial is testing

The Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicSkin SclerosisLung Fibrosis+2 more
Tokyo University 56
Testing effectiveness (Phase 2)Study completedNCT03222492
What this trial is testing

Brentuximab Vedotin for Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerodermadcSSc
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Study completedNCT01538719
What this trial is testing

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisDiffuse Scleroderma+1 more
Boston University 24
Not applicableEnrolling By InvitationNCT06472362
What this trial is testing

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Who this might be right for
Systemic Sclerosis
Royal Brompton & Harefield NHS Foundation Trust 1,000
Very early researchNot Yet RecruitingNCT07583030
What this trial is testing

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)Progressive Multiple Sclerosis (PMS)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 44
Testing effectiveness (Phase 2)Study completedNCT00622895
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

Who this might be right for
Systemic SclerodermaSevere Systemic Sclerosis
Fred Hutchinson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00147771
What this trial is testing

Imiquimod in Children With Plaque Morphea

Who this might be right for
Scleroderma, Localized
The Hospital for Sick Children 10
Large-scale testing (Phase 3)Looking for participantsNCT07497087
What this trial is testing

Test Whether Nerandomilast Helps People With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Boehringer Ingelheim 448
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07326033
What this trial is testing

Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma

Who this might be right for
Systemic Scleroderma
University Hospital, Toulouse 50
Not applicableStudy completedNCT03601520
What this trial is testing

Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis

Who this might be right for
Diffusion Limitation of Pulmonary Gas Exchange in Systemic Sclerosis
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 100
Next Page